1.87
price up icon3.31%   0.06
after-market Dopo l'orario di chiusura: 1.83 -0.04 -2.14%
loading

Gain Therapeutics Inc Azioni (GANX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- -0.3052 0.1054 0.0845
Operating Expenses
16.48%
5.0895
4.3694 3.3311 4.459 8.1828
Operating Income/Loss
16.48%
-5.0895
-4.3694 -3.3311 -4.459 -8.1828
Income/Loss From Continuing Operations Before Tax
27.96%
-5.6679
-4.4295 -3.2635 -4.4747 -8.1419
Income Tax Expense/Benefit
40.49%
0.1412
0.1005 0.5047 0.011 0.00121
Income/Loss From Continuing Operations After Tax
28.23%
-5.8091
-4.5301 -3.7682 -4.4857 -8.1431
Net Income/Loss
28.23%
-5.8091
-4.5301 -3.7682 -4.4857 -8.1431
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5.77%
30.34
28.69 1.608 26.53 19.22
Diluted Average Shares
5.77%
30.34
28.69 1.608 26.53 19.22
Basic Earnings Per Share
18.75%
-0.19
-0.16 -0.11 -0.17 -0.42
Diluted Earnings Per Share
18.75%
-0.19
-0.16 -0.11 -0.17 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):